Investor Insights

This summary was created by AI, based on 2 opinions in the last 12 months.

Experts have varied opinions on Brookfield Reinsurance, with one highlighting its strong performance post a major change in 2023 and future potential, while the other expressing concerns about the complexity of the company's structure. Despite differing opinions, both experts agree that the stock is undervalued and offers potential for gains in the future.

Consensus
Undecided
Valuation
Undervalued
BUY

It's done extremely well since the company made a major change in 2023 and has exceeded expectations. Almost no dividend, so returns are in the share price. This will continue to do well though now in a consolidation pattern. Good to own.

insurance
BUY
BN-T is offering shares of BNRE in a swap--accept it?

Unfortunately, Brookfield is looking like the old Brascan empire, a plate of spaghetti, where they spin off all these entities, then buy them back and it's hard to keep track of how many there are. That said, BAM and BN-T are grossly undervalued. The market is overreacting to the impact of commercial real estate BN-T, in particular. Do the swap.

insurance
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Brookfield Reinsurance(BNRE-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 2

Stockchase rating for Brookfield Reinsurance is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Brookfield Reinsurance(BNRE-T) Frequently Asked Questions

What is Brookfield Reinsurance stock symbol?

Brookfield Reinsurance is a Canadian stock, trading under the symbol BNRE-T on the Toronto Stock Exchange (BNRE-CT). It is usually referred to as TSX:BNRE or BNRE-T

Is Brookfield Reinsurance a buy or a sell?

In the last year, 2 stock analysts published opinions about BNRE-T. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Brookfield Reinsurance.

Is Brookfield Reinsurance a good investment or a top pick?

Brookfield Reinsurance was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Brookfield Reinsurance.

Why is Brookfield Reinsurance stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Brookfield Reinsurance worth watching?

In the last year, there was no coverage of Brookfield Reinsurance published on Stockchase.

What is Brookfield Reinsurance stock price?

On 2024-04-26, Brookfield Reinsurance (BNRE-T) stock closed at a price of $55.83.